The Dublin Maties Hub invites you, fellow Maties and Dubliners, to an online discussion with Dr Nicol van Dyk, Injury Surveillance and Medical Research Officer with the Irish Rugby Football Union.
COVID-19 has had a tremendous impact on team sports, both in its suspension during the global lockdown period and in its future as team sports resume under new measures to protect both the players and the public.
The Bundesliga are one of the first professional leagues to return to matches since lockdown. They have recorded a 33% increase in player injuries due to a limited or revised training regimen following COVID-19.
We will talk with Nicol about “Injury prevention: Risk mitigation strategies as professional sports enters its new normal” and what regimens should be implemented to minimise injuries both in professional sports and for you right at home.
Date: Thursday, 9 July 2020
Time: 12:30 — 13:30 (UTC+1)
Venue: Online
Where: Online (A link to the performance along with house rules will be sent on receipt of your RSVP)
RSVP: Email darrynh@sun.ac.za by 7 July 2020
More about Dr Nicol van Dyk
Nicol van Dyk is a clinical researcher and physiotherapist. He currently occupies the role of Injury Surveillance and Medical Research Officer with the Irish Rugby Football Union. He graduated with a BSc in Physiotherapy from Stellenbosch University in 2005 where he also completed an MSc in Orthopaedic Manipulative Therapy in 2010. Having worked in a number of different sporting environments, including athletics, rugby and football, he worked as physiotherapist at the Sport Science Institute of South Africa before moving to Doha, Qatar, in 2013 to join the Aspetar Orthopaedic and Sports Medicine Hospital. In 2018, Nicol completed his PhD in Health Sciences at Ghent University, Belgium, titled “Risk factors for hamstring injuries in professional football players”. Nicol is a deputy editor and editorial board member of the British Journal of Sports Medicine (BJSM) and also serves on the Research Advisory Group for Cirque du Soleil. He is enthusiastic about the development of new platforms to share scientific evidence and research knowledge.
